[In situ lymphoma and other early stage malignant non-Hodgkin lymphomas]

Pathologe. 2013 May;34(3):244-53. doi: 10.1007/s00292-013-1748-3.
[Article in German]

Abstract

The increasing use of immunohistochemical and molecular investigations of lymphatic tissues results in more frequent detection of early lymphoid proliferations. These show some but not all features of malignant lymphomas without fulfilling the diagnostic criteria for the diagnosis of lymphoid malignancy. In addition to well-known premalignant B-cell proliferations, such as monoclonal gammopathy of unknown significance (MGUS) and monoclonal B-cell lymphocytosis (MBL), so-called in situ lymphomas have recently been described with minimal infiltrates of clonal B-cells in morphologically reactive lymphoid tissues which show the phenotypic and genetic features of specific B-cell lymphoma subtypes and often show a characteristic topographical distribution. This article addresses a group of clonal lymphoproliferations with usually localized disease and excellent clinical prognosis, such as pediatric follicular lymphoma and nodal marginal zone lymphoma. Another group of early lesions not addressed in this review are virally induced lymphoproliferations which represent a grey zone between purely reactive lesions and malignant lymphomas and may pose significant diagnostic as well as clinical problems. In this review diagnostic criteria for early or in situ lesions and their distinction from partial infiltration by malignant lymphoma are described.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Adult
  • B-Lymphocytes / pathology*
  • Cell Proliferation
  • Cell Transformation, Neoplastic / pathology*
  • Child
  • Diagnosis, Differential
  • Humans
  • Lymphocytosis / pathology*
  • Lymphoid Tissue / pathology
  • Lymphoma, Follicular / pathology
  • Lymphoma, Non-Hodgkin / pathology*
  • Lymphoproliferative Disorders / pathology*
  • Monoclonal Gammopathy of Undetermined Significance / pathology
  • Neoplasm Staging